MI Metagenomi, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Metagenomi, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €44.8m. The latest transaction was disclosed on 8 December 2025 (Cession). Among the most active insiders: Wapnick Pamela. All data is accessible without an account.
€81,191
17 ops.
Sell Volume
Buys €951,077 €81,191 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 December 2025
All Executives33 Thresholds0 Prospectus0 Other0
Declarations 33 total
▼ See Remarks · Executives · 5 Dec 2025
199 shares @ US$1.7719 11.8% of flow Common Stock SEC:0001193125-25-310958:0
▼ Chief Financial Officer · Executives · 5 Dec 2025
1,576 shares @ US$1.7719 8.1% of flow Common Stock SEC:0001193125-25-310953:0
▼ Chief Executive Officer · Executives · 5 Dec 2025
1,602 shares @ US$1.7719 16.6% of flow Common Stock SEC:0001193125-25-310937:0
▼ Director · Executives · 5 Dec 2025
3,830 shares @ US$1.7719 22.0% of flow Common Stock SEC:0001193125-25-310971:0
▼ Director · Executives · 5 Sept 2025
2,701 shares @ US$1.81 20.3% of flow Common Stock SEC:0001193125-25-304221:0
▼ Chief Financial Officer · Executives · 5 Sept 2025
1,576 shares @ US$1.81 9.0% of flow Common Stock SEC:0001193125-25-304218:0
▼ Chief Executive Officer · Executives · 5 Sept 2025
1,602 shares @ US$1.81 20.3% of flow Common Stock SEC:0001193125-25-304212:0
▼ See Remarks · Executives · 5 Sept 2025
199 shares @ US$1.81 13.7% of flow Common Stock SEC:0001193125-25-304177:0
▼ See Remarks · Executives · 6 Jun 2025
199 shares @ US$1.75 15.6% of flow Common Stock SEC:0000950170-25-083963:0
▼ Chief Medical Officer · Executives · 6 Jun 2025
5,239 shares @ US$1.75 100.0% of flow Common Stock SEC:0000950170-25-083952:0
▼ Chief Financial Officer · Executives · 6 Jun 2025
1,576 shares @ US$1.75 9.8% of flow Common Stock SEC:0000950170-25-083949:0
▼ Chief Executive Officer · Executives · 6 Jun 2025
10,785 shares @ US$1.75 100.0% of flow Common Stock SEC:0000950170-25-083947:0
▼ See Remarks · Executives · 6 Jun 2025
6,390 shares @ US$1.75 100.0% of flow Common Stock SEC:0000950170-25-083930:0
◆ Chief Executive Officer · Executives · 1 Apr 2025
32,000 shares 0Common Stock SEC:0000950170-25-050102:0
◆ Chief Financial Officer · Executives · 1 Apr 2025
14,000 shares 0Common Stock SEC:0000950170-25-050103:0
◆ See Remarks · Executives · 1 Apr 2025
23,000 shares 0Common Stock SEC:0000950170-25-050101:0
◆ See Remarks · Executives · 1 Apr 2025
3,650 shares 0Common Stock SEC:0000950170-25-050100:0
◆ Chief Medical Officer · Executives · 1 Apr 2025
14,000 shares 0Common Stock SEC:0000950170-25-050098:0
▼ Chief Financial Officer · Executives · 5 Mar 2025
1,808 shares @ US$1.8748 14.4% of flow Common Stock SEC:0000950170-25-035565:0
▼ See Remarks · Executives · 5 Mar 2025
930 shares @ US$1.8748 100.0% of flow Common Stock SEC:0000950170-25-035566:0
▼ Chief Financial Officer · Executives · 5 Dec 2024
1,559 shares @ US$1.86 12.4% of flow Common Stock SEC:0000950170-24-134124:0
▼ Chief Financial Officer · Executives · 5 Sept 2024
6,265 shares @ US$2.88 73.2% of flow Common Stock SEC:0000950170-24-104439:0
◆ See Remarks · Executives · 1 Apr 2024
11,552 shares 0Common Stock SEC:0000950170-24-041515:0
◆ See Remarks · Executives · 1 Apr 2024
6,931 shares 0Common Stock SEC:0000950170-24-041483:0
◆ Chief Scientific Officer · Executives · 1 Apr 2024
69,316 shares 0Common Stock SEC:0000950170-24-041551:0
25 of 33 declarations
Load more (8 remaining) Acerca de Metagenomi, Inc. Metagenomi, Inc. es una empresa centrada en el desarrollo de tecnologías de ingeniería genética. Se concentra en aplicaciones terapéuticas para abordar enfermedades genéticas.